BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Insight

Daiichi Sankyo Targets Global Top Five Oncology Position By 2035

2.3 trillion yen in oncology revenue to be delivered by 2030 through the launch of 20 new indications across five medicines Identifying breakthrough g...

May 12, 2026 | News

Engineering Precision In Chromatography From Development To Commercial Scale

Chromatography in Bioprocessing For pilot and commercial purification of monoclonal antibodies and recombinant proteins, chromatography remains the centra...

April 24, 2026 | Analysis

Can AI close the MSK inequality gap? Improving access to musculoskeletal care in the UK

Behind these statistics lies a deeper and more troubling social divide: that the greatest burden is carried by those in our most deprived communities and m...

April 14, 2026 | Opinion | By Peter Grinbergs, Chief Medical Officer and Co‑founder of EQL

NCIS Leads Multidisciplinary Push To Transform Sarcoma Diagnosis And Care In Singapore

NCIS leads multi-institutional effort to develop expert multidisciplinary guidance to improve sarcoma diagnosis, referrals and outcomes Singapore is stren...

April 13, 2026 | News

From Staging to Survival: How AI-Driven Histological Analysis Is Solving Colorectal Cancer's Overtreatment Problem

The hidden cost of getting treatment decisions wrong Colorectal cancer (CRC) is one of the most prevalent and lethal cancers worldwide, ranking among the ...

April 02, 2026 | Expert Insight | By Dr. Torbjørn Furuseth, CEO and Co-Founder, DoMore Diagnostics

Taiwan Strengthens Its Position In Asia’s Next Phase Of Bioprocessing Growth

Taiwan’s bioprocessing and biotechnology sector has moved from a predominantly research-and-services footing toward a more industrialised, globally c...

March 20, 2026 | Analysis

From Concept to Validation-Ready: How Nelipak’s Singapore Hub Aims to Accelerate APAC Healthcare Packaging to Global Scale

Nelipak Healthcare Packaging has launched a new Asia-Pacific Technical Development Center in Singapore, establishing an integrated hub that unites ...

March 17, 2026 | Interaction

Turning Frontline Reality Into Policy Action For Cancer Care In Asia

Drawing on her frontline clinical experience in Malaysia, Prof Dr Wan Zamaniah, Consultant Clinical Oncologist, University Malaya Medical Centre&...

February 02, 2026 | Expert Insight

Closing Asia’s Cancer Evidence Gap Through Translational Science And Policy Leadership

In this BioPharma APAC interview, Dr Yun Yen, Program Committee Chair for the 2026 ASCO Breakthrough meeting, shares a candid translational...

February 02, 2026 | Expert Insight

China Originated Innovation Is Rising. Global Expectations Are Rising Even Faster.

The momentum is real—and so is the level of scrutiny. As more programs move beyond regional boundaries, expectations from global biopharma companies ...

February 02, 2026 | News | By Anil Kane, executive director, global head of technical and scientific affairs, Thermo Fisher Scientific

From Capacity to Capability: How 2026 can be the catalyst for what APAC’s Biopharma Growth Needs Next

Beyond Scale: What Will Sustain APAC’s Biopharma Leadership Asia-Pacific’s rise in global biopharma is no longer about whether the region can ...

January 21, 2026 | News | By Joonho Choi, Vice President, Asia-Pacific, Cytiva

Navigating European Regulatory and Market Access Pathways: Crucial Considerations from TMC’s Catherine Moncad

As more APAC biotech and pharma companies look to Europe for regulatory approval and commercialisation, navigating complex EU and UK requirements early is ...

January 19, 2026 | News

26 Key Trends Shaping Biotech And Life Sciences In 2026

As 2026 unfolds, biotech and life sciences are moving into a phase defined less by promise and more by execution. Faster R and D cycles, smarter cl...

January 05, 2026 | News

Leading the Future of Care: Patient Organizations Driving Health System Transformation

Real Change Starts with Listening Across the Asia Pacific, Middle East, and Africa, healthcare systems are facing mounting pressures with rising rates of ...

January 05, 2026 | Opinion | By Sung Lee, Executive Director, Region Communications and Patient Advocacy, Asia Pacific, Middle East, Africa (APMA), Novartis

Stay Connected